---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-021350"
form_type: "8-K"
ticker: "MNPR"
cik: "0001645469"
company_name: "Monopar Therapeutics"
filed_at: "2026-06-23T12:00:40+00:00"
generated_at: "2026-06-23T12:05:34.231691+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Monopar shareholders re-elect all directors, approve 2026 stock plan, ratify BPM

## Summary
- All six director nominees elected: Starr (4.20M for), Robinson (4.45M), Anderson (4.67M), Tsuchimoto (4.33M), Talukdar (4.90M), Sweeny (4.91M).
- Advisory say-on-pay passed with 4.36M for, 605k against, 651 abstain.
- 2026 Stock Incentive Plan approved with 4.44M for, 517k against.
- Ratification of BPM LLP as auditor for FY2026 passed with 5.76M for, 998 against.

## SEC filing metadata
- accession: 0001437749-26-021350
- form_type: 8-K
- ticker: MNPR
- cik: 0001645469
- company_name: Monopar Therapeutics
- filed_at: 2026-06-23T12:00:40+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645469/000143774926021350/0001437749-26-021350-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645469/000143774926021350/mnpr20260622_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-021350
- JSON: https://secwatch.observer/filing/0001437749-26-021350.json
- Plain text: https://secwatch.observer/filing/0001437749-26-021350.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.